|
|
|
 |
|
|
 |
 |
Pharmaceutical Product Development, Incorporated
Company
Snapshot Purchase a Full Report on this Company
Business Description:
Pharmaceutical Product Development, Incorporated. The Group's principal activity is to provide drug discovery and development services and products to pharmaceutical, biotechnology and medical device companies. The Group operates in two segments. The Development Sciences segment provides preclinical programs and clinical development services. The Discovery Sciences segment consists of functional genomics, which is the study of gene functions to identify drug targets within the body. This segment also provides biological chemistry research and preclinical biology services. It offers post-market support services for drugs receiving approval for market use. These services include product launch services, patient compliance programs and medical communications programs for consumer and healthcare providers on product use and adverse events.
|
|
| |
Wright Quality Rating:
AAA1 Rating Explanations |
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (2/5/2010):
22.50
(Figures in
U.S. Dollars) |
|
1 Week |
-3.7% |
|
13 Weeks |
-1.4% |
|
|
|
|
|
|
|
|
|
4 Weeks |
7.5% |
|
52 Weeks |
-14.3% |
|
|
|
| |
| |
Pharmaceutical Product Development, Incorporated
Key Data: |
|
|
|
| |
Ticker: |
PPDI |
Country: |
UNITED STATES |
| |
|
| |
Exchanges: |
NAS |
Major Industry: |
Miscellaneous |
| |
|
| |
|
|
Sub Industry: |
Medical Services |
| |
|
| |
2008
Sales |
1,569,901,000
(Year Ending Jan 2009). |
Employees: |
10,500 |
| |
|
| |
Currency: |
U.S. Dollars |
Market Cap: |
2,658,620,453 |
| |
|
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
118,160,909 |
| |
|
| |
Share Type: |
Common |
Closely Held Shares: |
11,550,515 |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for Pharmaceutical Product Development, Incorporated, are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
Pharmaceutical Product Development, Incorporated company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze Pharmaceutical Product Development, Incorporated Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight Pharmaceutical Product Development, Incorporated
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of Pharmaceutical Product Development, Incorporated Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|